Improved survival of IPF patients treated with antifibrotic drugs compared with untreated patients
M. Platenburg (Nieuwegein, Netherlands), C. Van Moorsel (Nieuwegein, Netherlands), I. Wiertz (Nieuwegein, Netherlands), P. Zanen (Nieuwegein, Netherlands), J. Van Der Vis (Nieuwegein, Netherlands), A. Vorselaars (Nieuwegein, Netherlands), M. Veltkamp (Nieuwegein, Netherlands), J. Grutters (Nieuwegein, Netherlands)
Source: International Congress 2022 – How to prevent progression in idiopathic interstitial pneumonias
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Platenburg (Nieuwegein, Netherlands), C. Van Moorsel (Nieuwegein, Netherlands), I. Wiertz (Nieuwegein, Netherlands), P. Zanen (Nieuwegein, Netherlands), J. Van Der Vis (Nieuwegein, Netherlands), A. Vorselaars (Nieuwegein, Netherlands), M. Veltkamp (Nieuwegein, Netherlands), J. Grutters (Nieuwegein, Netherlands). Improved survival of IPF patients treated with antifibrotic drugs compared with untreated patients. 2657
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|